サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1793891

血栓治療の世界市場

Thrombus Treatment

出版日
ページ情報
英文 296 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.98円
血栓治療の世界市場
出版日: 2025年08月19日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 296 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血栓治療の世界市場は2030年までに557億米ドルに達する見込み

2024年に408億米ドルと推定される血栓治療の世界市場は、2024～2030年の分析期間にCAGR 5.3％で成長し、2030年には557億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである心房血栓型は、CAGR 6.8%を記録し、分析期間終了時には280億米ドルに達すると予測されます。右心房血栓型セグメントの成長率は、分析期間中CAGR 3.6%と推定されます。

米国市場は111億米ドルと推定、中国はCAGR 8.7%で成長予測

米国の血栓治療市場は、2024年に111億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに113億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と5.3％と予測されています。欧州では、ドイツがCAGR 3.5%で成長すると予測されています。

世界の血栓治療市場- 主要動向と促進要因まとめ

血栓管理は緊急対応から標的介入へ進化？

血栓治療は、かつては抗凝固療法や機械的血栓除去術のような緊急介入を中心とした反応的なものであったが、現在は大きな変革期を迎えています。臨床的理解が深まり、治療アルゴリズムが進化するにつれて、血栓管理は、より早期に、より正確に、患者に特異的な戦略へと移行しつつあります。血栓-血管内に形成された血の塊-は、深部静脈血栓症（DVT）、肺塞栓症（PE）、心筋梗塞、虚血性脳卒中などの生命を脅かす病態を引き起こす可能性があります。血栓塞栓症の世界の負担は、人口の高齢化と座りがちなライフスタイルによって増大し、ヘルスケアシステムは拡張性のある先進的な治療アプローチを求め続けています。

現代の血栓治療は、薬物療法、カテーテルを用いた介入、予防医療という3つの柱を特徴としています。抗凝固薬がほとんどの治療計画の基盤であることに変わりはないが、カテーテルを用いた血栓溶解療法、吸引血栓除去術、新規の機械的デバイスなどが高リスク症例や難治性症例では一般的になりつつあります。さらに、認知度と検出能力の向上により、血栓の早期診断が可能となり、時には臨床症状が現れる前であっても、高リスクの患者群では先制治療が可能となりつつあります。このパラダイムシフトは、血栓ケアを危機管理から継続的なリスク軽減と個別化治療へと再定義しつつあります。

薬剤の革新と血管内デバイスはどのように治療基準を再定義しているのか？

薬理学的な面では、アピキサバン、リバーロキサバン、エドキサバンなどの直接経口抗凝固薬（DOACs）の開発は、ワルファリンと比較して予測可能な薬物動態、モニタリングの必要性の低減、出血リスクの低減をもたらし、血栓治療の状況を一変させました。これらの薬剤は、心房細動におけるDVT、PE、脳卒中予防のために、病院と外来の両方でますます使用されるようになっています。また、外科手術や外傷患者に対する安全性を高めるために、選択性の高い次世代抗血栓薬や逆転薬の研究も進んでいます。

一方、機械的血栓除去術やカテーテル直接血栓溶解療法（CDT）の台頭は、急性血栓事象に対する治療プロトコルを大きく変えつつあります。これらの低侵襲的手技により、標的を絞った血栓除去や局所的なドラッグデリバリーが可能となり、全身への曝露や出血合併症を最小限に抑えることができます。吸引カテーテル、自己拡張型ステントリトリーバー、超音波アシスト血栓溶解システムなどのデバイスは、脳、肺、冠動脈、末梢などの血管床における有効性を高めるために微調整されています。機械的治療と薬理学的治療を組み合わせたハイブリッド治療が可能になったことで、特に即時の灌流回復を必要とする脳卒中や脳血管性心疾患患者において、血栓溶解の迅速化と機能的転帰の改善がもたらされています。

早期発見、リスクプロファイリング、予防療法は市場を拡大できるか？

血栓治療における重要な動向は、予防と早期のリスク特定に重点が置かれていることです。ウェアラブル技術、AI支援画像診断、予測リスクスコアリングツールは、術後患者、妊婦、心房細動やがん患者などの高リスク集団の血栓傾向を検出するために使用されています。これらのツールにより、臨床医は予防的治療を早期に開始し、入院率を低下させることができます。外科手術の場面では、術中の血栓モニタリングと周術期の抗凝固療法プロトコールが標準化され、手術後の合併症を最小限に抑えるようになっています。

長期的な血栓管理も拡大しつつあり、特に再発を繰り返す患者や慢性血栓塞栓性肺高血圧症（CTEPH）患者への対応が進んでいます。外来抗凝固クリニック、遠隔INRモニタリング、在宅ケアモデルなどにより、生涯にわたる血栓管理がより身近で持続可能なものとなりつつあります。さらに、バイオマーカー、遺伝的素因、併存疾患に基づく患者の層別化が重視されるようになり、より精緻でリスク調整された治療計画が可能になりつつあります。このような精密なアプローチは、個別化された投与レジメン、ニッチ診断、個別化されたデバイスの展開など、血栓治療における新たなサブマーケットを生み出しています。

血栓治療市場の成長を加速させている要因は何か？

血栓治療市場の成長は、治療イノベーション、インターベンション技術、臨床ワークフロー統合に関連する複数の収束要因によって牽引されています。第一に、安全性、有効性、使いやすさからDOACの採用が拡大し、入院・外来両方の血栓治療が再構築されつつあります。第二に、脳梗塞、PE、末梢血栓におけるカテーテルを用いた機械的血栓除去術の普及は、低侵襲治療の新たな基準を確立しつつあります。

第三に、画像診断（CT血管造影、超音波二重層法など）の向上とAIによるリスク評価ツールの使用により、より迅速な診断とより正確な治療開始が可能になってきています。第4に，人口の高齢化，肥満率の上昇，心房細動の有病率の増加などの人口統計学的要因により，リスクのある患者層が拡大し，より積極的な予防的治療的介入が必要となっています。第5に、器具の小型化、柔軟なカテーテル技術、画像誘導システムの統合など、現在進行中の技術革新が血管内治療をより安全で効果的なものにしています。最後に、バリュー・ベース・ケアと一括償還モデルへのシフトが、合併症、再入院、治療費全体を削減する血栓管理プロトコルの採用を病院に促しています。このような動きの収束により、血栓治療は血管・循環器治療において最も革新的で臨床的にダイナミックなセグメントのひとつとなっています。

セグメント

タイプ（心房血栓タイプ,右心房血栓タイプ,左心房血栓タイプ,静脈血栓タイプ）;治療（内科的治療,抗血小板治療,抗凝固薬治療,血栓溶解薬治療,外科的治療,その他の治療）

調査対象企業の例

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Bayer AG
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardinal Health, Inc.
  • Cook Medical
  • Daiichi Sankyo Company, Limited
  • Edwards Lifesciences Corporation
  • Genentech（F. Hoffmann-La Roche）
  • Inari Medical, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer Inc.
  • Stryker Corporation

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP38206

Global Thrombus Treatment Market to Reach US$55.7 Billion by 2030

The global market for Thrombus Treatment estimated at US$40.8 Billion in the year 2024, is expected to reach US$55.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Atrial Thrombus Type, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$28.0 Billion by the end of the analysis period. Growth in the Right Atrial Thrombus Type segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.1 Billion While China is Forecast to Grow at 8.7% CAGR

The Thrombus Treatment market in the U.S. is estimated at US$11.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Thrombus Treatment Market - Key Trends & Drivers Summarized

Is Thrombus Management Evolving From Emergency Response to Targeted Intervention?

Thrombus treatment, once largely reactive and centered around emergency interventions like anticoagulation and mechanical thrombectomy, is now undergoing a significant transformation. As clinical understanding deepens and treatment algorithms evolve, thrombus management is moving toward earlier, more precise, and patient-specific strategies. A thrombus-a blood clot formed within a vessel-can lead to life-threatening conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, and ischemic stroke. The global burden of thromboembolic disorders, amplified by aging populations and sedentary lifestyles, continues to push healthcare systems toward scalable, advanced treatment approaches.

Modern thrombus treatment is characterized by three pillars: pharmacological therapy, catheter-based intervention, and preventive care. While anticoagulants remain the foundation for most treatment plans, catheter-directed thrombolysis, aspiration thrombectomy, and novel mechanical devices are becoming common in high-risk or refractory cases. Additionally, growing awareness and detection capabilities are enabling earlier diagnosis of thrombi, sometimes even before clinical symptoms manifest-leading to preemptive therapy in high-risk patient groups. This paradigm shift is redefining thrombus care from crisis management to continuous risk mitigation and personalized therapy.

How Are Drug Innovations and Endovascular Devices Redefining Care Standards?

On the pharmacological front, the development of direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and edoxaban has changed the landscape of thrombus treatment by offering predictable pharmacokinetics, reduced monitoring needs, and lower bleeding risk compared to warfarin. These agents are increasingly used in both hospital and outpatient settings for DVT, PE, and stroke prevention in atrial fibrillation. Research is also advancing into next-generation antithrombotics with higher selectivity and reversal agents that enhance safety profiles for surgical or trauma patients.

Meanwhile, the rise of mechanical thrombectomy and catheter-directed thrombolysis (CDT) is transforming treatment protocols for acute thrombotic events. These minimally invasive procedures allow for targeted clot removal or localized drug delivery, minimizing systemic exposure and bleeding complications. Devices such as aspiration catheters, self-expanding stent retrievers, and ultrasonic-assisted thrombolysis systems are being fine-tuned to enhance efficacy across vascular beds-cerebral, pulmonary, coronary, and peripheral. The ability to combine mechanical and pharmacological therapies in hybrid procedures is yielding faster clot resolution and better functional outcomes, particularly in stroke and PE patients who require immediate restoration of perfusion.

Can Early Detection, Risk Profiling, and Preventive Therapies Expand Market Reach?

A critical trend in thrombus treatment is the emphasis on prevention and early risk identification. Wearable technologies, AI-assisted imaging, and predictive risk scoring tools are being used to detect thrombotic tendencies in high-risk populations-such as post-operative patients, pregnant women, and individuals with atrial fibrillation or cancer. These tools enable clinicians to initiate prophylactic therapy earlier and reduce hospitalization rates. In surgical settings, intraoperative thrombus monitoring and perioperative anticoagulation protocols are being standardized to minimize post-procedure complications.

Long-term thrombus management is also expanding, especially for patients with recurrent events or chronic thromboembolic pulmonary hypertension (CTEPH). Outpatient anticoagulation clinics, remote INR monitoring, and home-based care models are making lifelong thrombus management more accessible and sustainable. Moreover, increasing focus on patient stratification-based on biomarkers, genetic predisposition, and comorbidities-is enabling more refined, risk-adjusted therapy plans. This precision approach is creating new submarkets within thrombus care, including personalized dosage regimens, niche diagnostics, and tailored device deployment.

What Factors Are Accelerating Growth in the Thrombus Treatment Market?

The growth in the thrombus treatment market is driven by multiple converging factors related to therapeutic innovation, interventional techniques, and clinical workflow integration. First, the expanding adoption of DOACs-due to their safety, efficacy, and ease of use-is reshaping both inpatient and outpatient thrombus care. Second, the increasing use of catheter-based and mechanical thrombectomy systems in stroke, PE, and peripheral thrombi is establishing new standards in minimally invasive treatment.

Third, improvements in diagnostic imaging (e.g., CT angiography, duplex ultrasound) and the use of AI-assisted risk assessment tools are enabling faster diagnosis and more accurate therapy initiation. Fourth, demographic factors such as aging populations, rising obesity rates, and the increasing prevalence of atrial fibrillation are swelling the at-risk patient pool, prompting more aggressive prophylactic and therapeutic interventions. Fifth, ongoing innovations in device miniaturization, flexible catheter technologies, and integrated imaging-guided systems are making endovascular approaches safer and more effective. Lastly, the shift toward value-based care and bundled reimbursement models is encouraging hospitals to adopt thrombus management protocols that reduce complications, readmissions, and overall treatment costs. These dynamics are converging to make thrombus treatment one of the most innovation-driven and clinically dynamic segments in vascular and cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Thrombus Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type, Venous Thrombus Type); Treatment (Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment, Surgery Treatment, Other Treatments)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Bayer AG
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardinal Health, Inc.
  • Cook Medical
  • Daiichi Sankyo Company, Limited
  • Edwards Lifesciences Corporation
  • Genentech (F. Hoffmann-La Roche)
  • Inari Medical, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer Inc.
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Thrombus Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular and Stroke-Related Events Fuels Demand for Thrombus Therapies
    • Adoption of Catheter-Directed Thrombolysis Supports Minimally Invasive Treatment Growth
    • Increased Use of Mechanical Thrombectomy Devices Enhances Acute Stroke Intervention Success
    • Advancements in Clot-Dissolving Agents Improve Efficacy in DVT and PE Management
    • Expansion of Interventional Cardiology Capabilities Drives Procedural Volumes for Clot Removal
    • Rising Awareness of Venous Thromboembolism Prevention in Post-Surgical Settings Supports Prophylactic Drug Use
    • Integration of Imaging Technologies With Treatment Planning Enhances Patient Selection Accuracy
    • Development of Next-Gen Devices With Reduced Embolization Risk Supports Adoption in High-Risk Patients
    • Growth in Stroke Centers and Specialized Units Enhances Access to Timely Thrombus Treatment
    • Demand for Rapid-Recovery Solutions Drives Hospital Preference for Mechanical Devices Over Systemic Agents
    • Increased Investment in Stroke and Vascular Health Campaigns Supports Early Presentation and Diagnosis
    • Growing Pipeline of Anti-Thrombotic Agents Expands Therapeutic Options in Refractory Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Thrombus Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Thrombus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Right Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Right Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Right Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Left Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Left Atrial Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Left Atrial Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Venous Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Venous Thrombus Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Venous Thrombus Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Medical Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Medical Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Medical Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Antiplatelets Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Antiplatelets Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Antiplatelets Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Anticoagulants Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Anticoagulants Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Anticoagulants Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Thrombolytics Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Thrombolytics Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Thrombolytics Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Surgery Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Surgery Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • JAPAN
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • CHINA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • EUROPE
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Thrombus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • FRANCE
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • GERMANY
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Thrombus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • INDIA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Thrombus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Thrombus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Thrombus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030
  • AFRICA
    • Thrombus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Thrombus Treatment by Type - Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Thrombus Treatment by Type - Percentage Breakdown of Value Sales for Atrial Thrombus Type, Right Atrial Thrombus Type, Left Atrial Thrombus Type and Venous Thrombus Type for the Years 2014, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Thrombus Treatment by Treatment - Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Thrombus Treatment by Treatment - Percentage Breakdown of Value Sales for Other Treatments, Medical Therapy Treatment, Antiplatelets Treatment, Anticoagulants Treatment, Thrombolytics Treatment and Surgery Treatment for the Years 2014, 2025 & 2030

IV. COMPETITION